Raid M. Aljumaily
Raid M. Aljumaily publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research and Lung Cancer Research Studies.
- World rank
- #872,389 of 7,710,434 ranked researchers
- Rank in United States
- #288,591 of 1,627,098
- Works
- 155
- Citations
- 3.4k
- Citations per work
- 21.7
What does Raid M. Aljumaily research?
Raid M. Aljumaily's work is mostly in Medicine (64%), Biochemistry, Genetics and Molecular Biology (10%), Immunology and Microbiology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences9963.6%
- Medicine9963.6%
- Everything else3421.7%
- Life Sciences2314.7%
- 1Oncology42% of their works
- 2Pulmonary and Respiratory Medicine18% of their works
- 3Molecular Biology6% of their works
- 4Immunology5% of their works
- 5Epidemiology4% of their works
- 6Cancer Research4% of their works
Research topics
Which keywords describe Raid M. Aljumaily's research?
The keywords of their largest research topics: Immunotherapy, Tumor Microenvironment, Immune Checkpoint Blockade, PD-1 and PD-L1, Clinical Trials, Targeted Therapy, Chemotherapy and Cancer Immunotherapy.
- Dendritic Cells
- Breast Cancer
- Metastatic
- Pancreatic Cancer
- ALK Inhibitors
- Genomic Profiles
- CAR T Cells
- Cancer Immunotherapy
- Targeted Therapy
- PD-1 and PD-L1
- Tumor Microenvironment
- Immunotherapy
- Immune Checkpoint Blockade
- Clinical Trials
- Chemotherapy
- Prognostic Factors
- Chimeric Antigen Receptor
- Small-Cell Lung Cancer
- EGFR Mutations
- Surgical Complications
- Renal Cell Carcinoma
- CDK4/6 Inhibitors
- Immunity
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Immunotherapy734 topics
- Tumor Microenvironment702 topics
- Immune Checkpoint Blockade551 topic
- PD-1 and PD-L1551 topic
- Clinical Trials382 topics
- Targeted Therapy382 topics
- Chemotherapy352 topics
- Cancer Immunotherapy342 topics
- Prognostic Factors342 topics
- CAR T Cells241 topic
- Chimeric Antigen Receptor241 topic
- Genomic Profiles201 topic
- Small-Cell Lung Cancer201 topic
- ALK Inhibitors181 topic
- EGFR Mutations181 topic
- Pancreatic Cancer151 topic
- Surgical Complications151 topic
- Metastatic141 topic
- Renal Cell Carcinoma141 topic
- Breast Cancer111 topic
- CDK4/6 Inhibitors111 topic
- Dendritic Cells101 topic
- Immunity101 topic
Where does Raid M. Aljumaily work?
Raid M. Aljumaily's main affiliation in the publication record is Sarah Cannon, United States.
How many publications and citations does Raid M. Aljumaily have?
OpenAlex counts 155 works and 3,366 citations for Raid M. Aljumaily, an h-index of 24, ranking #872,389 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Raid M. Aljumaily. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.